Similar Articles
Electroencephalographic Findings in Patients with COVID-19: A Single-center Experience
Nur Türkmen, Ahmet Buğrul, Bülent Oğuz Genç
DOI: 10.4274/tnd.2021.76329
Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population
Gizem Yağmur Yalçın, Cansu Polat Dunya, Zeliha Tülek, Murat Kürtüncü, Mefkure Eraksoy
DOI: 10.4274/tnd.2021.63444
Guillain-Barré Syndrome with Bilateral Peripheral Facial Nerve Paralysis After COVID-19 Infection
Özgül Ocak
DOI: 10.4274/tnd.2021.78095
Donepezil Treatment of Hypersomnia After COVID-19
Demet Aygün Üstel, Pervin İşeri, Meltem Can İke
DOI: 10.4274/tnd.2021.29726
Is a Brain Stroke Caused by COVID-19 Seen Under Two Years of Age? A Case Report
Mohammad Vafaee Shahi, Sedigheh Yousefzadegan, Ramin Zare Mahmoudabadi, Fatemeh Ahmadi, Aina Riahi
DOI: 10.4274/tnd.2021.42492
A Case Report of Acute Disseminated Encephalomyelitis in a Pregnant Woman After COVID-19 Infection
Rukiye Kızılırmak, Miraç Özalp, Mehmet Armağan Osmanağaoğlu, Cavit Boz
DOI: 10.4274/tnd.2021.25675
Post COVID-19 Rhino-Orbital-Cerebral Mucormycosis: The Guitar Pick Sign
Kiran Kumar Ramineni, Krishna Mohan Reddy Gangireddy, Sashidhar Reddy Gutha, Ravi Kanth Jakkani, Ugandhar Bhattu
DOI: 10.4274/tnd.2021.35493
Guillain Barré Syndrome: A Rare Neurological Manifestation of COVID-19
Amina Chentouf
DOI: 10.4274/tnd.2021.03453
Encephalitis, Reversible Splenial Lesions, and COVID-19
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
DOI: 10.4274/tnd.2021.90093
Pandemic-Triggered Aberrant Drug Use may Cause Failure of Antiepileptic Therapy
Manolya Bergüzar Şekerlisoy, Aslıhan Taşkıran Sağ
DOI: 10.4274/tnd.2021.45804
Guillain-Barré Syndrome and COVID-19 Vaccines: A Comment
Joob Beuy, Viroj Wiwanitkit
DOI: 10.4274/tnd.2021.47048
Magnetic Resonance Imaging in the Diagnosis of Multiple Sclerosis
Rana KARABUDAK